Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

Adrenomedullin 2 stops cell growth and causes cell death in human hair follicles.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Phenytoin and spironolactone help prevent hair loss from chemotherapy by reducing stress and inflammation.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Females had more chemotherapy side effects than males, with many being preventable.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

Researchers made new compounds that could potentially be developed into anticancer drugs.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Minoxidil can harm dog's heart.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Chemotherapy often causes skin, hair, and nail problems in cancer patients.

Chemotherapy drugs can cause abnormal growth and changes in healthy skin and gland cells.

A 72-year-old man was diagnosed with a rare skin form of Rosai-Dorfman disease after years of misdiagnosis.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

Tamoxifen increases the risk of lasting hair loss after chemotherapy despite scalp cooling.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

New cancer treatments aim to reduce side effects and improve effectiveness.

Bleomycin injections in mice cause skin thickening and hair loss.

A man had bad reactions to a hair loss treatment called DNCB.

Certain genes can predict how well breast cancer patients respond to chemotherapy.